Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Immunology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Atopic Dermatitis Clinical Trials

A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (156) clinical trials

The purpose of this study is to evaluate the efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis.

Phase

Eczema holding you back? If you are 18 years or older and struggle with eczema, you may qualify for a new clinical research study. The study is for an investigational eczema medication that is delivered as an injection at the doctor’s office.

Phase N/A

A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of an injectable medication, tralokinumab, in combination with topical corticosteroids in subjects with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.

Phase

Now enrolling ages 18 and older for moderate to severe atopic dermatitis.

Phase N/A

This is a double-blind, randomized, placebo-controlled study to assess the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus (itching) in adults with prurigo nodularis (abbreviated as PN, a skin condition with multiple very itchy, solid skin bumps that develop due to scratching).  All enrolled subjects will receive ...

Phase

This study will be evaluating the efficacy, tolerability and safety of lebrikizumab compared to placebo in subjects with moderate to severe atopic dermatitis. This is a phase 2b, randomized, placebo-controlled, double-blind study in which subjects will be randomized to receive either lebrikizumab 125mg every 4 weeks, 250mg every 2 weeks, ...

Phase

This registry aims to characterize the patients who receive DUPIXENT for atopic dermatitis (AD) in a real world setting, with respect to their medical history, socio-demographic and disease characteristics, and prior and concomitant treatments of AD.

Phase

The OXFORAD™ Study for Atopic Dermatitis is examining an investigational drug to see how safe and effective it is when given to people like you who have eczema.

Phase N/A

A research study is evaluating an investigational medication for moderate to severe atopic dermatitis, also known as eczema.

Phase N/A

A Randomized, Double-Blind, Placebo-Controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

Phase